Company Overview
- Headquarters
- 3350 Riverwood Parkway, Suite 1900, Vinings GA
- Website
- inhibikase.com
- Phone
- (678) 392-3419
- Employees
- 7
- Industry
- Materials/Manufacturing
Financials & Stats
Revenue
$3B
Who is Inhibikase Therapeutics Inc
Inhibikase Therapeutics Inc. is a clinical-stage pharmaceutical company headquartered in Atlanta, Georgia. Currently employing 7 individuals, the company focuses on developing innovative treatments for Parkinson's disease. Inhibikase Therapeutics specializes in developing small-molecule kinase inhibitor therapeutics. Their mission is to create treatments that effectively modify Parkinson's disease, aiming for functional reversal both within and outside the brain. A key differentiator for Inhibikase Therapeutics is their dedication to developing therapies that target kinase inhibitors, a promising avenue for treating Parkinson's disease. Their research focuses on achieving functional reversal, aiming to not only manage symptoms but potentially reverse the progression of the disease. For more information about Inhibikase Therapeutics, visit their website at inhibikase.com.
Company Leadership
Companies Similar to Inhibikase Therapeutics Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Inhibikase Therapeutics Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | Vicksburg, MI | ||
| 3M | 3 | Florida, FL | ||
| 3M | 9 | Orem, UT | 1993 | |
| 3M | ||||
| 3M | 25 | 2016 |